Nearly all the ex vivo expanded mesoderm-derived fibroblasts from normal breast, and CAFs from primary and brain metastatic tumors expressed the common mesenchyme markers CD44, CD90, CD105, CD166, and CD140β (Fig. 1c). The gene discussed is CD44; the disease is metastatic neoplasm.